Determination of oxaliplatin in human plasma and plasma ultrafiltrate by graphite-furnace atomic-absorption spectrometry

A method for sensitive determination of the anti-cancer agent oxaliplatin in human plasma and human plasma ultrafiltrate (pUF) is presented. The method is based on the quantification of platinum by graphite-furnace atomic-absorption spectrometry, with Zeeman correction and an atomisation temperature of 2,700°C. Sample pretreatment involves dilution of the samples with a solution containing 0.15 mol L^–1 NaCl and 0.20 mol L^–1 HCl in water. Validation was performed in accordance with the most recent FDA guidelines for bioanalytical method validation. All results were within requirements. The validated ranges of quantification were 0.10–400 mol L^–1 for human pUF and 0.50–400 mol L^–1 for plasma. The assay is now successfully used to support pharmacokinetic studies of cancer patients treated with oxaliplatin.     

Release of prostaglandin E(1) from N-(2-hydroxypropyl)methacrylamide copolymer conjugates by bone cells

Bone-targeting N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer-PGE(1) conjugates, containing cathepsin K sensitive spacers, were incubated with induced osteoclasts and osteoblasts, their precursors, and control non-skeletal cells. The release of PGE(1) was monitored by an HPLC assay. In both murine and human cell lines, osteoclasts appeared to be the most active cells in the cleavage (PGE(1) release). Incubation with osteoblasts also resulted in fast PGE(1) release, whereas precursor and control cells released PGE(1) with a substantially slower rate than bone cells (apparently through ester bond cleavage). Experiments in the presence of inhibitors revealed that other enzymes, in addition to cathepsin K, were participating in the cleavage of the conjugate. Confocal fluorescence studies exposed internalization of the conjugate by endocytosis with ultimate localization in the lysosomal/endosomal compartment.     

Determination of ruthenium originating from the investigational anti-cancer drug NAMI-A in human plasma ultrafiltrate, plasma, and urine by inductively coupled plasma mass spectrometry

We present a highly sensitive, rapid method for the determination of ruthenium originating from the investigational anti-cancer drug NAMI-A in human plasma ultrafiltrate, plasma, and urine. The method is based on the quantification of ruthenium by inductively coupled plasma mass spectrometry and allows quantification of 30 ng L(-1) ruthenium in plasma ultrafiltrate and urine, and 75 ng L(-1) ruthenium in human plasma, in 150 microL of matrix. The sample pretreatment procedure is straightforward and only involves dilution with appropriate diluents. The performance of the method, in terms of accuracy and precision, fulfilled the most recent FDA guidelines for bioanalytical method validation. Validated ranges of quantification were 30.0 to 1 x 10(4) ng L(-1) for ruthenium in plasma ultrafiltrate and urine and 75.0 to 1 x 10(4) ng L(-1) for ruthenium in plasma. The applicability of the method and its superiority to atomic-absorption spectrometry were demonstrated in two patients who were treated with intravenous NAMI-A in a phase I trial. The assay is now successfully used to support pharmacokinetic studies in cancer patients treated with NAMI-A.     

Validated method for the determination of platinum from a liposomal source (SPI-77) in human plasma using graphite furnace Zeeman atomic absorption spectrometry

A sensitive analytical method based on flameless atomic absorption spectrometry with Zeeman correction has been validated for the quantitative determination in human plasma of platinum originating from cisplatin in a liposomal source, SPI-77. The performance of the method was acceptable over a sample concentration range of 0.125–1.25 μmol platinum/L and the lower limit of quantification was determined to be 1.25 μmol platinum/L in undiluted clinical samples. The performance data of the assay were investigated using both a calibration curve with carboplatin in plasma ultrafiltrate and diluted human plasma samples spiked with SPI-77. The recoveries, between-day and the within-day precisions of both methods of calibration were not significantly different allowing carboplatin ultrafiltrate calibration standards to be used to quantify platinum derived from SPI-77 in human plasma. Apparently, the liposomal formulation had no significant influence on the determination of platinum. The usefulness of the presented method was demonstrated in a phase I clinical and pharmacokinetic study. In addition, in vitro experiments were carried out to determine the distribution of SPI-77 in blood. The results indicated that platinum from SPI-77 mainly concentrates in plasma and that binding to and/or endocytosis in red blood cells is negligible.     

Validated method for the determination of platinum from a liposomal source (SPI-77) in human plasma using graphite furnace Zeeman atomic absorption spectrometry

A sensitive analytical method based on flameless atomic absorption spectrometry with Zeeman correction has been validated for the quantitative determination in human plasma of platinum originating from cisplatin in a liposomal source, SPI-77. The performance of the method was acceptable over a sample concentration range of 0. 125-1.25 micromol platinum/L and the lower limit of quantification was determined to be 1.25 micromol platinum/L in undiluted clinical samples. The performance data of the assay were investigated using both a calibration curve with carboplatin in plasma ultrafiltrate and diluted human plasma samples spiked with SPI-77. The recoveries, between-day and the within-day precisions of both methods of calibration were not significantly different allowing carboplatin ultrafiltrate calibration standards to be used to quantify platinum derived from SPI-77 in human plasma. Apparently, the liposomal formulation had no significant influence on the determination of platinum. The usefulness of the presented method was demonstrated in a phase I clinical and pharmacokinetic study. In addition, in vitro experiments were carried out to determine the distribution of SPI-77 in blood. The results indicated that platinum from SPI-77 mainly concentrates in plasma and that binding to and/or endocytosis in red blood cells is negligible.     

火试金减杂-电感耦合等离子体原子发射光谱法（ICP-AES）法测定高冰镍的金、银、铂、钯含量

建立了火试金减杂-电感耦合等离子体原子发射光谱法（ICP-AES）测定高冰镍中金、银、铂、钯含量的分析方法。实验采用火试金富集、熔融、灰吹得到合粒,通过减杂法得到银含量,通过ICP-AES法测定得到金、铂、钯含量。金、银、铂、钯的加标回收率在99.53%-101.83%之间,相对标准偏差小于3%。此方法快速、简洁,准确度高、精密度好,能够满足高冰镍的测定需求。     

Quantitation of N,N,N',N'-tetrakis (2-hydroxypropyl)-ethylenediamine in plasma by gas chromatography

A wide-bore capillary gas chromatographic method with nitrogen-selective thermionic detection is described for the quantitative analysis of N,N,N',N'-tetrakis (2-hydroxypropyl)ethylenediamine (Quadrol) in plasma. N,N,N',N'-tetrakis (2-hydroxybutyl)ethylenediamine is used as an internal standard. Rat or human plasma samples (0.5 ml) are mixed with internal standard, adjusted to alkaline pH and subjected to a single extraction with dichloromethane. Quadrol recovery from plasma typically exceeds 90%. The method is linear over the range 1.0-50 micrograms/ml. The working detection limit is 0.5 microgram/ml and the analysis time is under 7 min. The procedure has been used to obtain plasma concentration versus time data for the evaluation of Quadrol pharmacokinetics in rats.     

Efficient resolution of 2,2'-dihydroxy-1,1'-binaphthyl by inclusion complexation with chiral N-(3-chloro-2-hydroxypropyl)-N,N,N-trimethylammonium chloride

The complete resolution of 2,2[prime or minute]-dihydroxy-1,1[prime or minute]-binaphthyl into its enantiomers by inclusion complexation with a commercially available derivative of choline, is reported. The two enantiomers are recovered in >99% ee from the inclusion complexes by simple dissolution in a diethyl ether-water medium and the resolving agent can be recycled.     

Determination of (2,3-epoxypropyl)trimethylammonium chloride, (3-chloro-2-hydroxypropyl)trimethylammonium chloride, and (2,3-dihydroxypropyl)trimethylammonium chloride by capillary electrophoresis

Capillary electrophoresis (CE) is a powerful technique to determine (2,3-epoxypropyl)trimethylammonium chloride, (3-chloro-2-hydroxypropyl)trimethylammonium chloride and their hydrolysis product (2,3-dihydroxypropyl)trimethylammonium chloride in complex matrices. The separation was performed in a 180 mM copper(II) sulphate-4 mM formic acid buffer at pH 3. The UV inactive target compounds were detected by indirect UV detection at 215 nm with a reference wavelength of 300 nm--copper(II) being the chromophor. The results were compared to data acquired by ion-pair HPLC with perchlorate as ion pair former in a 1 M aqueous sodium perchlorate solution in 0.2 mM phosphoric acid (pH 3.4) on a RP 18 column and refractive index detection as reference method. Results of both methods are in good agreement.     

Determination of donepezil hydrochloride (E2020) in plasma by liquid chromatography-mass spectrometry and its application to pharmacokinetic studies in healthy, young, Chinese subjects

A sensitive, simple, and specific liquid chromatographic method coupled with electrospray ionization-mass spectrometry for the determination of donepezil in plasma is developed, and its pharmacokinetics in healthy, male, Chinese is studied. Using loratadine as the internal standard, after extraction of the alkalized plasma by isopropyl alcohol-n-hexane (3:97, v/v), solutes are separated on a C(18) column with a mobile phase of methanol-acetate buffer (pH 4.0) (80:20, v/v). Detection is performed with a time-of-flight mass spectrometer equipped with an electrospray ionization source operated in the positive-ionization mode. Quantitation of E2020 is accomplished by computing the peak area ratio (donepezil [M+H](+) m/z 380-loratadine [M+H](+) m/z 383) and comparing them with the calibration curve (r = 0.9998). The linear calibration curve is obtained in the concentration range 0.1-15 ng/mL. The limit of quantitation is 0.1 ng/mL. The mean recovery of E2020 from human plasma is 99.4% +/- 6.3% (ranging 93.4-102.6%). The inter- and intraday relative standard deviation is less than 15%. After an oral administration of 5 mg E2020 to 20 healthy Chinese volunteers, the main pharmacokinetic parameters of E2020 are as follow: T(max), 3.10 +/- 0.55 h; t((1/2)), 65.7 +/- 12.8 h; C(max), 10.1 +/- 2.02 ng/mL; MRT, 89.4 +/- 13.4 h; and CL/F, 9.9 +/- 4.3 L/h.     

Determination of four thiophenethylamine designer drugs (2C-T-series) in human plasma by capillary electrophoresis with mass spectrometry detection

In recent years, the frequent appearance of phenethylamine designer drugs on the illicit drug market has been a matter of concern for all authorities involved. New phenethylamine drugs are being introduced because these compounds are not covered by existing legislation. Therefore, the new drugs cannot be considered illicit drugs until their names are officially recognized. This paper describes a method to screen for and quantify four 2,5-methylenedioxy-derivatives of 4-thio-phenethylamine (2C-T-series) in human plasma, using capillary electrophoresis coupled with electrospray ionisation-mass spectrometry (CE-ESI-MS). Prior to CE-MS analysis, a simple liquid extraction was used for sample cleanup. The method was validated according to international guidelines.     

Determination of palladium(II) with alpha-(2-benzimidazolyl)-alpha',alpha'-(N-5-nitro-2-pyridylhydrazone)-toluene by adsorptive cathodic stripping voltammetry

The determination of palladium(II) complexed with alpha-(2-benzimidazolyl)-alpha',alpha'-(N-5-nitro-2-pyridylhydrazone)-Toluene (BINPHT) was investigated by adsorptive cathodic stripping voltammetry using hanging mercury drop electrode. Palladium(II) in the sample solution can be determined in BINPHT and ethylenediaminetetraacetic acid (EDTA). Accumulation is achieved by adsorption of Pd(II)-BINPHT complex on a hanging mercury drop electrode. Optimal conditions were found to be: supporting electrolyte; 0.01 M sodium acetate buffer at pH 5.0, accumulation potential; -590 mV versus Ag/AgCl, accumulation time; 180 s, scan rate; 50 mV s(-1), concentration of BINPHT; 2x10(-5) M. The linear range of Pd(II) was observed over the concentration range 20-100 ng ml(-1) The detection limit (S/N=3) is 2 ng ml(-1). A good reproductivity shows RSD of 2.0% (n=7). This procedure offers high selectivity with the presence of EDTA masking some metallic ions. River water sample spiking with palladium was determined.     

Determination of iron, copper and zinc in tinned mussels by inductively coupled plasma atomic emission spectrometry (ICP-AES)

Summary An optimisation of the ICP-AES determination of Fe, Cu and Zn in tinned mussels has been carried out. The optimum conditions for the radio frequency power, peristaltic pump flow, plasma gas flow, nebuliser gas pressure, auxiliary gas flow and observation height above load coil were determined manually for each element, since the Simplex method was less adequate. Scans were carried out with the aim of finding the most sensitive spectral lines, whose intensity did not always coincide with literature data. Limits of detection, linearity, precision, and accuracy were also investigated. The possible spectral interferences due to Na, K, Ca, Mg, P, I and nitric acid were studied from three different points of view and the results did not agree. The influence of the matrix on the determination of the above elements in tinned food from the Galician Rias (in the south coast of Galicia) was also studied. The results obtained were comparable to those obtained by AAS.     

Determination,by inductively coupled plasma mass spectrometry,of changes in cellular metal content resulting from herpes simplex virus-1 (HSV-1) infection

Metals and metal-containing compounds are known to play important roles in many biological processes, including metabolic and detoxification pathways and the formation and function of proteins. Like all organisms, viruses are expected to contain different metals. These metals, either by themselves or in the form of metalloproteins, may be involved in the virus’s ability to infect healthy cells and replicate within them. Identification and speciation of metals in control cells and in cells affected by a virus could be helpful in elucidating infection and replication mechanisms; these might, in turn, be vital to the development of more effective treatments. There has, however, been no extensive investigation of the metals specific viruses contain or affect. The objective of this study was to investigate changes in cellular metal content resulting from herpes simplex virus 1 (HSV-1) infection. Inductively coupled plasma mass spectrometry was used to identify differences between metal concentrations in uninfected and HSV-1-infected mammalian cells. Although it can be assumed that decreases in metal content are a result of cellular response to the virus, increases can be attributed either to cellular response or to the HSV-1 virus itself. Microwave digestion and flow injection methods suitable for small sample volumes were used, and the effects of different virus inactivation procedures were explored. This work is the first step in the identification of metals pertinent to HSV-1 infection and lays the foundation for future studies concentrating on characterization of these metal-associated or containing molecules.     

电感耦合等离子体原子发射光谱(ICP-OES)法测定硫磺中的铅、铜、铁、镍、钙

提出了电感耦合等离子体原子原子发射光谱测定硫磺中的铅、铜、铁、镍、钙含量的方法,选择各元素的分析谱线,采用正交试验的方法确定仪器的工作参数,方法的检出限0.0046 ug/ml-0.012 ug/ml,方法的回收率在87.60%~111.78%,测定值的相对标准偏差(n=5)小于9.82%,填补无硫磺中铅、铜、镍、钙元素检测方法的空白。     

Determination of nickel in biological samples by inductively coupled plasma spectrometry after extraction with 1,5-bis(di-2-pyridylmethylene)thiocarbonohydrazide

Summary An ICP-AES method for the determination of nickel subtraces after extraction of the metal into methyl isobutyl ketone(MIBK) containing 1,5-bis-(di-2-pyridylmethylene)thiocarbonohydrazide is suggested. The complex formed is quite soluble in MIBK, so that the determination of concentrations down to 15 times lower than those by the direct non-extractive method is possible. In addition, the extraction step enhances the selectivity. The described method was applied to the determination of nickel in various biological materials, such as red cabbage, algae, liver, kidney, brain and urine.     

Determination of N-(3-acetamidopropyl)pyrrolidin-2-one, a metabolite of spermidine, in urine by isotope dilution mass fragmentography

A capillary gas chromatographic method with mass spectrometric detection for the determination of N-(3-acetamidopropyl)pyrrolidin-2-one, the monoacetyl conjugate of isoputreanine-gamma-lactam, in urine has been developed. Using a quantification based on stable isotope dilution mass fragmentography, age-dependent normal values for the urinary excretion of N-(3-acetamidopropyl)pyrrolidin-2-one by 44 apparently healthy control subjects were determined. Quality control data and normal values for 27 adults are given. The method was applied to the monitoring of the chemotherapeutic treatment of two patients with high-grade non-Hodgkin lymphoma.     

Determination of traces of uranium and thorium in (Ba, Sr) TiO3 ferroelectrics by inductively coupled plasma mass spectrometry

 Traces of uranium and thorium in barium(II), strontium(II) titanate ((Ba, Sr)TiO₃) ferroelectric materials were determined by inductively coupled plasma mass spectrometry (ICP-MS). Samples were completely dissolved by a mixture of 1.4% H₂O₂ and 1.0 mol⋅l^-1 HNO₃. For a complete separation of the analytes from the matrix elements, a two step separation technique involving leaching and anion-exchange was applied. By the leaching step with HNO₃ more than 90% of the matrix can be removed whereas the analytes completely remained in the solution. The anion-exchange step was carried out on a BIO⋅RAD AG1-X8 column with a mixture of 1.0 mol⋅l^-1 HF and 0.5 mol⋅l^-1 HNO₃ as eluent. The content of uranium and thorium was subsequently measured by ICP-MS. The detection limits (D.L.) obtained were 0.043 ng g^-1 and 0.035 ng g^-1 for U and Th, respectively. The reproducibility was satisfactory with a relative standard deviation of less than 3% (at the 1 ng g^-1 level, n=5). The matrix concentrations in the final solution were reduced to the sub-μg ml^-1 level which is in the range of the detection limits of USN-ICP-AES (ultrasonic nebulization-ICP-atomic emission spectroscopy). The method was successfully applied to the determination of uranium and thorium in three synthetic (Ba, Sr)TiO₃ samples spiked with the analytes at levels of 1, 5 and 10 ng g^-1 and three (Ba, Sr)TiO₃ ferroelectric samples containing sub-ng g^-1 levels of the analytes. Received: 26 February 1996/Revised: 28 May 1996/Accepted: 5 June 1996     

Determination of traces of uranium and thorium in (Ba, Sr) TiO3 ferroelectrics by inductively coupled plasma mass spectrometry

 Traces of uranium and thorium in barium(II), strontium(II) titanate ((Ba, Sr)TiO₃) ferroelectric materials were determined by inductively coupled plasma mass spectrometry (ICP-MS). Samples were completely dissolved by a mixture of 1.4% H₂O₂ and 1.0 mol⋅l^-1 HNO₃. For a complete separation of the analytes from the matrix elements, a two step separation technique involving leaching and anion-exchange was applied. By the leaching step with HNO₃ more than 90% of the matrix can be removed whereas the analytes completely remained in the solution. The anion-exchange step was carried out on a BIO⋅RAD AG1-X8 column with a mixture of 1.0 mol⋅l^-1 HF and 0.5 mol⋅l^-1 HNO₃ as eluent. The content of uranium and thorium was subsequently measured by ICP-MS. The detection limits (D.L.) obtained were 0.043 ng g^-1 and 0.035 ng g^-1 for U and Th, respectively. The reproducibility was satisfactory with a relative standard deviation of less than 3% (at the 1 ng g^-1 level, n=5). The matrix concentrations in the final solution were reduced to the sub-μg ml^-1 level which is in the range of the detection limits of USN-ICP-AES (ultrasonic nebulization-ICP-atomic emission spectroscopy). The method was successfully applied to the determination of uranium and thorium in three synthetic (Ba, Sr)TiO₃ samples spiked with the analytes at levels of 1, 5 and 10 ng g^-1 and three (Ba, Sr)TiO₃ ferroelectric samples containing sub-ng g^-1 levels of the analytes. Received: 26 February 1996/Revised: 28 May 1996/Accepted: 5 June 1996